Retisert 0.59 MG Intravitreal Drug Implant

RxCUI: 1191325
RxNorm name: Retisert 0.59 MG Intravitreal Drug Implant
Display name: Retisert 0.59 MG Intravitreal Drug Implant
Full name: Retisert 0.59 MG Intravitreal Drug Implant
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Retisert	FLUOCINOLONE ACETONIDE	Bausch & Lomb Incorporated	1ab0f849-2a0d-47ce-ad05-768094da8cc9	2026-03-31	Warnings, Adverse reactions	Exact identifier rxcui: 1191325

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
1ab0f849-2a0d-47ce-ad05-768094da8cc9	Retisert 0.59 MG Intravitreal Drug Implant [PSN] · fluocinolone acetonide 0.59 MG Drug Implant [Retisert] [SBD] · Retisert 0.59 MG Drug Implant [SY]	3	16	These highlights do not include all the information needed to use RETISERT safely and effectively. See full prescribing information for RETISERT. RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg, for intravitreal use Initial U.S. Approval: 1963	20260331